A detailed history of Regentatlantic Capital LLC transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Regentatlantic Capital LLC holds 1,118 shares of WST stock, worth $351,599. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,118
Holding current value
$351,599
% of portfolio
0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$246.08 - $343.65 $275,117 - $384,200
1,118 New
1,118 $276,000
Q2 2022

Aug 15, 2022

SELL
$280.61 - $420.45 $240,482 - $360,325
-857 Closed
0 $0
Q1 2022

May 02, 2022

BUY
$357.49 - $445.92 $104,029 - $129,762
291 Added 51.41%
857 $352,000
Q4 2021

Jan 27, 2022

BUY
$402.25 - $471.34 $227,673 - $266,778
566 New
566 $265,000

Others Institutions Holding WST

About WEST PHARMACEUTICAL SERVICES INC


  • Ticker WST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,033,000
  • Market Cap $23.3B
  • Description
  • West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...
More about WST
Track This Portfolio

Track Regentatlantic Capital LLC Portfolio

Follow Regentatlantic Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Regentatlantic Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regentatlantic Capital LLC with notifications on news.